Livzon

搜索

Search

这是描述信息



Home
About Livzon 
Chairman's Speech Company Profile Milestones Leaders' Caring Honors Corporate Vision
Media 
Livzon News Employment system
Investor Relations 
Governance Announcements Financial Report ESG Report Shareholder Return Stock Information Contacts
Sustainable Development 
ESG Reports Human Development Business Ethics Suppliers Environment, Occupational Health and Safety (EHS) Philanthropy ESG Rating and Honors
Products 
Leading Products Product List ADR Reporting
R&D 
R&D Platforms Livzon Microsphere Livzon Bio Livzon Research Institute R&D Achievements IP Achievements
Overseas Market 
Overseas Business Specialty Products Certificates Contacts
Join Us 
Social recruitment Campus Recruit Compensation and benefits Contacts

News Center

/

/

/

Overseas Regulatory Announcement

All categories 



Overseas Regulatory Announcement

ANNOUNCEMENT ON OBTAINING APPROVAL NOTICE FOR CLINICAL TRIAL ON A DRUG

Keywords: Time of issue: Size of file:

 E_ORA_20210407_ess1617787491864

2021-04-07

144KB

Select all

上一个 NOTICE OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING 下一个 VOLUNTARY ANNOUNCEMENT UPDATE ON ACQUISITION OF 40.00% EQUITY INTEREST IN TIANJIN TONGRENTANG

1

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China Tel： 0756-8135888

©2021 Livzon 粤ICP备05025993号 Support：300.cn

Home | E-Mail | Legal Declaration

Home | E-Mail | Legal Declaration

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China

©2021 Livzon 粤ICP备05025993号

Support：300.cn